Saturday 17 October 2026
Export UFPT’s income statement to Excel — free account
UFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
291.67
5.52
−1.86%
Follow UFPT
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
23.20 | 21.87 | 15.48 | 18.65 | 26.03 | 33.30 | 20.94 | 28.16 | 31.80 | 25.03 |
Piotroski F-Score |
5 | 7 | 6 | 7 | 5 | 2 | 6 | 6 | 5 | 5 |
P/S ratio |
1.27 | 1.35 | 1.16 | 1.86 | 1.94 | 2.56 | 2.47 | 3.16 | 3.72 | 2.84 |
Altman Z-Score |
10.37 | 11.24 | 5.09 | 10.95 | 10.44 | 3.95 | 6.16 | 9.24 | 6.07 | 6.86 |
P/FCF ratio |
87.58 | 28.15 | 13.82 | 14.47 | 16.79 | 58.66 | 81.85 | 40.99 | 34.89 | 21.65 |
Altman Z″-Score (non-manufacturers) |
13.96 | 14.92 | 6.83 | 10.77 | 11.77 | 4.41 | 5.55 | 6.90 | 4.95 | 6.00 |
Beneish M-Score |
(2.24) | (2.76) | (1.11) | (2.66) | (2.74) | (3.04) | (1.70) | (2.26) | (2.50) | (2.57) |
P/Operating CF |
60.94 | 44.78 | 28.40 | 41.65 | 42.02 | 858.18 | 48.87 | 99.55 | 76.76 | 101.59 |
P/B ratio |
1.64 | 1.61 | 1.57 | 2.27 | 1.97 | 2.72 | 3.68 | 4.42 | 5.47 | 4.04 |
Price to Tangible BV |
1.76 | 1.72 | 3.32 | 4.13 | 3.31 | 27.89 | 15.57 | 11.63 | 211.83 | 19.98 |
EV/Sales |
1.06 | 1.09 | 1.27 | 1.85 | 1.82 | 2.91 | 2.61 | 3.23 | 4.09 | 3.05 |
EV/EBITDA |
8.66 | 9.34 | 8.84 | 11.18 | 13.03 | 20.24 | 13.74 | 18.69 | 21.58 | 16.50 |
EV/Operating CF |
16.63 | 9.27 | 11.38 | 11.77 | 13.01 | 41.95 | 52.12 | 31.24 | 30.98 | 20.02 |
EV/FCF |
73.19 | 22.82 | 15.19 | 14.44 | 15.68 | 66.54 | 86.58 | 41.86 | 38.39 | 23.28 |
Quick Ratio |
5.59 | 6.07 | 1.64 | 1.95 | 3.35 | 1.30 | 1.06 | 1.22 | 1.35 | 1.45 |
Current Ratio |
7.31 | 7.55 | 2.69 | 3.17 | 4.75 | 2.25 | 2.08 | 2.48 | 2.56 | 2.69 |
Net Debt/EBITDA |
(1.71) | (2.19) | 0.80 | (0.02) | (0.92) | 2.40 | 0.75 | 0.39 | 1.97 | 1.16 |
Debt/Assets |
0.67% | 0.00% | 13.26% | 1.64% | 0.62% | 24.58% | 14.54% | 7.92% | 32.08% | 22.81% |
Debt/Equity |
0.01 | 0.00 | 0.18 | 0.02 | 0.01 | 0.42 | 0.23 | 0.11 | 0.59 | 0.35 |
Asset Turnover |
1.18 | 1.11 | 1.16 | 1.05 | 0.92 | 0.77 | 0.99 | 1.02 | 0.98 | 0.94 |
Operating CF/Net income |
1.17 | 1.90 | 1.49 | 1.58 | 1.87 | 0.90 | 0.42 | 0.92 | 1.13 | 1.35 |
Capex/Depreciation |
(1.28) | (1.84) | (0.68) | (0.71) | (0.52) | (0.63) | (0.59) | (0.92) | (0.87) | (0.67) |
Interest Coverage |
177.35 | 233.86 | 14.86 | 36.66 | 201.59 | 544.05 | 20.05 | 15.82 | 10.04 | 9.42 |
| 7.36% | 7.78% | 10.83% | 13.06% | 7.89% | 8.56% | 19.35% | 17.16% | 18.76% | 17.82% | |
| 6.44% | 6.92% | 8.73% | 10.44% | 6.82% | 5.91% | 11.73% | 11.48% | 11.42% | 10.64% | |
ROIC |
9.26% | 8.52% | 7.55% | 9.57% | 6.79% | 5.00% | 12.02% | 11.52% | 9.52% | 10.44% |
Return on Tangible Assets |
7.32% | 7.75% | 15.45% | 21.19% | 12.10% | 15.11% | 35.28% | 30.24% | 31.17% | 33.28% |
Average Days of Receivables |
55.09 | 55.30 | 58.66 | 53.22 | 53.78 | 69.67 | 56.86 | 59.98 | 64.88 | 53.42 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
16.50% | 16.05% | 14.52% | 14.74% | 15.33% | 14.29% | 12.94% | 12.72% | 12.33% | 12.85% |
Intangible Assets out of Total Assets |
0.06 | 0.05 | 0.39 | 0.39 | 0.35 | 0.53 | 0.48 | 0.44 | 0.53 | 0.52 |
Share Based Compensation of Revenue |
0.72% | 0.72% | 0.64% | 0.80% | 1.01% | 1.18% | 0.91% | 1.16% | 1.36% | 1.47% |
Graham Net Nets |
0.30 | 0.30 | 0.03 | 0.07 | 0.13 | (0.10) | (0.03) | 0.02 | (0.05) | (0.02) |
Graham Number |
19.82 | 22.00 | 28.89 | 36.14 | 30.85 | 35.03 | 62.45 | 70.52 | 87.94 | 104.78 |
Earnings Yield |
4.31% | 4.57% | 6.46% | 5.36% | 3.84% | 3.00% | 4.78% | 3.55% | 3.15% | 3.99% |
Free Cash Flow Yield |
1.14% | 3.55% | 7.24% | 6.91% | 5.96% | 1.70% | 1.22% | 2.44% | 2.87% | 4.62% |
Revenue per Share |
20.32 | 20.40 | 25.92 | 26.72 | 23.97 | 27.42 | 46.77 | 52.48 | 65.78 | 78.23 |
Operating CF per Share |
1.29 | 2.41 | 2.90 | 4.21 | 3.35 | 1.90 | 2.35 | 5.42 | 8.68 | 11.93 |
Capex per Share |
(1.00) | (1.43) | (0.73) | (0.78) | (0.57) | (0.70) | (0.93) | (1.38) | (1.68) | (1.67) |
Free Cash Flow per Share |
0.29 | 0.98 | 2.17 | 3.43 | 2.78 | 1.20 | 1.41 | 4.05 | 7.01 | 10.26 |
Cash per Share |
4.36 | 5.24 | 0.44 | 0.50 | 3.24 | 1.48 | 0.59 | 0.69 | 1.75 | 2.63 |
Shareholders Equity per Share |
15.72 | 17.07 | 19.12 | 21.82 | 23.64 | 25.84 | 31.40 | 37.53 | 44.70 | 55.01 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
15.72 | 17.07 | 19.12 | 21.82 | 23.64 | 25.84 | 31.40 | 37.53 | 44.70 | 55.01 |
Free Cash Flow |
2.11 | 7.09 | 15.97 | 25.46 | 20.78 | 9.01 | 10.68 | 30.85 | 53.75 | 79.03 |
Working Capital |
60.29 | 65.13 | 34.97 | 36.47 | 56.73 | 48.54 | 60.39 | 86.42 | 118.65 | 126.14 |
Capital Expenditures |
(7.19) | (10.37) | (5.35) | (5.77) | (4.26) | (5.28) | (7.06) | (10.49) | (12.85) | (12.87) |
Net Current Asset Value |
54.97 | 60.58 | 6.49 | 26.48 | 45.55 | (52.37) | (24.30) | 26.59 | (91.29) | (30.20) |
EV/EBIT |
12.64 | 13.84 | 12.37 | 14.88 | 19.47 | 28.26 | 16.69 | 22.39 | 25.50 | 19.93 |
Capex to Sales |
0.05 | 0.07 | 0.03 | 0.03 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 |
Price to Operating Income |
15.13 | 17.08 | 11.25 | 14.91 | 20.84 | 24.91 | 15.78 | 21.93 | 23.18 | 18.53 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.12 | 0.11 | 0.14 | 0.14 | 0.15 | 0.15 | 0.20 | 0.18 | 0.21 | 0.24 |
Cash ROIC |
1.46% | 4.39% | 9.46% | 15.08% | 10.27% | 3.13% | 3.60% | 9.54% | 9.63% | 13.31% |
Accounts Receivable Turnover |
7.23 | 6.65 | 7.19 | 6.66 | 6.48 | 6.27 | 7.49 | 6.62 | 6.49 | 6.78 |
Accounts Payable Turnover |
25.93 | 27.46 | 25.81 | 25.31 | 30.97 | 21.07 | 17.24 | 13.63 | 15.37 | 17.81 |
Inventory Turnover |
7.86 | 8.32 | 8.76 | 7.63 | 7.30 | 5.96 | 6.06 | 4.65 | 4.54 | 4.96 |
Average Days of Payables |
13.10 | 13.58 | 17.55 | 11.57 | 11.17 | 24.95 | 27.65 | 28.26 | 24.76 | 20.50 |
Days of Inventory on Hand |
46.33 | 41.79 | 50.27 | 46.19 | 50.52 | 78.63 | 74.15 | 89.00 | 89.32 | 73.32 |
Average Receivables |
20.20 | 22.23 | 26.50 | 29.77 | 27.68 | 32.91 | 47.25 | 60.43 | 77.70 | 88.94 |
Average Payables |
4.30 | 4.09 | 5.51 | 5.71 | 4.35 | 7.37 | 15.29 | 21.12 | 23.28 | 24.28 |
Average Inventory |
14.18 | 13.51 | 16.22 | 18.93 | 18.46 | 26.04 | 43.49 | 61.86 | 78.86 | 87.20 |
Average Assets |
123.78 | 133.07 | 163.90 | 189.18 | 195.98 | 268.67 | 356.16 | 391.16 | 516.57 | 642.04 |
Average Common Equity |
108.31 | 118.38 | 132.08 | 151.22 | 169.44 | 185.67 | 216.00 | 261.82 | 314.43 | 383.32 |
Columns are period end dates